NASDAQ: SURG
Surgepays Inc Earnings Dates, Reports, Calls

Surgepays earnings were -$36.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest SURG earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$13.9M, up 85.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SURG reported annual earnings of -$36.1M, with -21.1% growth.

SURG earnings history

Current Revenue
$57.0M
Current Earnings
-$36.1M
Current Profit Margin
-63.3%

SURG Return on Equity

Current Company
N/A
Current Industry
31.2%
Current Market
28.9%

SURG Return on Assets

Current Company
-267.7%
Current Industry
10.8%
SURG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SURG announces earnings.

SURG Return on Capital Employed

Current Company
352.11%
Current Industry
16.3%
SURG has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SURG vs App Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SURG-$32.95M-$36.07MN/A-$1.80
IDAI-$7.26M-$8.33MN/A-$2.67
WETON/A-$3.09MN/A-$0.14
YMTN/AN/AN/AN/A
SPPL-$2.27M-$3.27MN/A-$0.56

Surgepays Earnings Reports & History FAQ

What were Surgepays's earnings last quarter?

Surgepays (NASDAQ: SURG) reported Q4 2025 earnings per share (EPS) of -$0.69, up 32.35% year over year. Total SURG earnings for the quarter were -$13.86 million. In the same quarter last year, Surgepays's earnings per share (EPS) was -$1.02.

If you're new to stock investing, here's how to buy Surgepays stock.

Is Surgepays profitable or losing money?

As of the last Surgepays earnings report, Surgepays is currently losing money. Surgepays's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$36.07 million, a 21.13% decrease year over year.

What was SURG's earnings growth in the past year?

As of Surgepays's earnings date in Q2 2026, Surgepays's earnings has grown year over year. SURG earnings in the past year totalled -$36.07 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.